600129 Stock Overview
Chongqing Taiji Industry(Group) Co.,Ltd produces and sells Chinese patent medicines, western medicines, Chinese herbal medicines, and other products in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Chongqing Taiji Industry(Group) Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥34.92 |
| 52 Week High | CN¥68.44 |
| 52 Week Low | CN¥29.75 |
| Beta | 0.58 |
| 1 Month Change | 2.02% |
| 3 Month Change | -2.97% |
| 1 Year Change | -29.30% |
| 3 Year Change | 133.42% |
| 5 Year Change | 207.67% |
| Change since IPO | 298.75% |
Recent News & Updates
Is Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) Trading At A 33% Discount?
Mar 18
Chongqing Taiji Industry(Group)Ltd (SHSE:600129) Has A Pretty Healthy Balance Sheet
Feb 28Shareholder Returns
| 600129 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 6.1% | 4.9% | 2.1% |
| 1Y | -29.3% | -13.4% | -14.2% |
Return vs Industry: 600129 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 600129 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 600129 volatility | |
|---|---|
| 600129 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600129 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600129's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 12,589 | Min Yu | www.taiji.com |
Chongqing Taiji Industry(Group) Co.,Ltd produces and sells Chinese patent medicines, western medicines, Chinese herbal medicines, and other products in China. It offers its products in various areas, such as digestive system and metabolism, respiratory system, cardiovascular and cerebrovascular, systemic anti-infective drugs, endocrine system drugs, nervous system drugs, general health products, etc. The company was incorporated in 1979 and is headquartered in Chongqing, China.
Chongqing Taiji Industry(Group) Co.,Ltd Fundamentals Summary
| 600129 fundamental statistics | |
|---|---|
| Market cap | CN¥19.45b |
| Earnings (TTM) | CN¥834.00m |
| Revenue (TTM) | CN¥15.40b |
23.3x
P/E Ratio1.3x
P/S RatioIs 600129 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600129 income statement (TTM) | |
|---|---|
| Revenue | CN¥15.40b |
| Cost of Revenue | CN¥8.21b |
| Gross Profit | CN¥7.19b |
| Other Expenses | CN¥6.36b |
| Earnings | CN¥834.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.50 |
| Gross Margin | 46.69% |
| Net Profit Margin | 5.41% |
| Debt/Equity Ratio | 102.4% |
How did 600129 perform over the long term?
See historical performance and comparison